Nirmatrelvir/ritonavir (Paxlovid) in the prevention of long-term cardiovascular outcomes: The paxloviD Effectiveness For the prEvention of loNg coviD (DEFEND) clinical trial
- Granting Agency
 - Long COVID Web
 - Principal Investigators
 - Quinn K
 - Co-Investigators
 - Verma A, Razak F
 - Grant Type
 - Innovation Fund
 - Grant Amount
 - $100,000
 
